loadpatents
name:-0.019363164901733
name:-0.01544713973999
name:-0.0098559856414795
Searle; Xenia B. Patent Filings

Searle; Xenia B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Searle; Xenia B..The latest application filed is for "modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use".

Company Profile
14.18.27
  • Searle; Xenia B. - Grayslake IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20220211692 - Hardee; David J. ;   et al.
2022-07-07
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20210238159 - Altenbach; Robert J. ;   et al.
2021-08-05
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,988,454 - Altenbach , et al. April 27, 2
2021-04-27
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,981,890 - Altenbach , et al. April 20, 2
2021-04-20
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,844,041 - Altenbach , et al. November 24, 2
2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,844,042 - Altenbach , et al. November 24, 2
2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,829,473 - Altenbach , et al. November 10, 2
2020-11-10
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277273 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use
App 20200277275 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277276 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277274 - Altenbach; Robert J. ;   et al.
2020-09-03
Substituted Pyrrolidines and Methods of Use
App 20190315687 - Altenbach; Robert J. ;   et al.
2019-10-17
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,428,017 - Altenbach , et al. October 1, 2
2019-10-01
Substituted Tricyclics and Method of Use
App 20190135827 - Altenbach; Robert J. ;   et al.
2019-05-09
Substituted Chromanes and Method of Use
App 20190127356 - Altenbach; Robert J. ;   et al.
2019-05-02
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20190077784 - Altenbach; Robert J. ;   et al.
2019-03-14
Modulators of cystic fibrosis transmembrane conductance regulator protein
Grant 10,118,916 - Altenbach , et al. November 6, 2
2018-11-06
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20180244640 - Altenbach; Robert J. ;   et al.
2018-08-30
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20180244611 - Altenbach; Robert J. ;   et al.
2018-08-30
Substituted Tricyclics and Method of Use
App 20180037587 - Altenbach; Robert J. ;   et al.
2018-02-08
Substituted tricyclics and method of use
Grant 9,840,513 - Altenbach , et al. December 12, 2
2017-12-12
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein
App 20170305891 - Altenbach; Robert J. ;   et al.
2017-10-26
Substituted Chromanes And Method Of Use
App 20170190693 - Altenbach; Robert J. ;   et al.
2017-07-06
Substituted chromanes and method of use
Grant 9,642,831 - Altenbach , et al. May 9, 2
2017-05-09
Substituted tetrahydropyrans and method of use
Grant 9,567,322 - Kym , et al. February 14, 2
2017-02-14
Substituted Tricyclics And Method Of Use
App 20170015675 - Altenbach; Robert J. ;   et al.
2017-01-19
Substituted Chromanes And Method Of Use
App 20160120841 - Kym; Philip R. ;   et al.
2016-05-05
Substituted Tetrahydropyrans And Method Of Use
App 20160122331 - Kym; Philip R. ;   et al.
2016-05-05
Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
Grant 8,796,470 - Searle , et al. August 5, 2
2014-08-05
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
Grant 8,691,865 - Searle , et al. April 8, 2
2014-04-08
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
Grant 8,129,417 - Stewart , et al. March 6, 2
2012-03-06
SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS
App 20110294854 - Searle; Xenia B. ;   et al.
2011-12-01
Novel Substituted Octahydrocyclopenta[c]pyrrol-4-amines As Calcium Channel Blockers
App 20110281870 - Searle; Xenia B. ;   et al.
2011-11-17
Antibacterial compounds
Grant 7,737,159 - Anderson , et al. June 15, 2
2010-06-15
Novel Substituted Octahydrocyclopenta[c]pyrrol-4-amines As Calcium Channel Blockers
App 20100130558 - Stewart; Andrew O. ;   et al.
2010-05-27
Antibacterial Compounds
App 20070142353 - Anderson; David D. ;   et al.
2007-06-21
Antibacterial compounds
Grant 7,196,200 - Anderson , et al. March 27, 2
2007-03-27
Azabicyclic compounds are central nervous system active agents
App 20060287290 - Dart; Michael J. ;   et al.
2006-12-21
Azabicyclic compounds are central nervous system active agents
Grant 7,135,484 - Dart , et al. November 14, 2
2006-11-14
Antibacterial compounds
App 20050159423 - Anderson, David D. ;   et al.
2005-07-21
Azabicyclic compounds are central nervous system active agents
App 20040152724 - Dart, Michael J. ;   et al.
2004-08-05
3-Amino-2-hydroxyalkanoic acids and their prodrugs
App 20040122098 - BaMaung, Nwe Y. ;   et al.
2004-06-24
Azabicyclic compounds are central nervous system active agents
App 20040044029 - Dart, Michael J. ;   et al.
2004-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed